Fund: FTBDF
Franklin Templeton - Franklin Biotechnology Discovery Fund A(acc)USD - 4912 | |
LU0109394709 | |
03-04-2000 | |
Equity | |
Equity Sectors - Health Care | |
Franklin Templeton Investment Funds | |
Franklin Advisers, Inc. | |
Evan McCulloch | |
USD | |
1,000 | |
5.75% |
1M | 3M | 6M | 9M | 1R | 3R p.a. | 5R p.a. | 7R p.a. | 10R p.a. | od vnizku p.a. | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Výkonnosť fondu | 1.77% | -1.90% | 14.45% | 21.94% | 21.19% | -1.96% | 6.78% | 5.00% | 5.24% | N/A | |
Priemerná výkonnosť (36 meraní) | 0.15% | -2.79% | 0.61% | 3.28% | 2.63% | ||||||
Volatilita od priemernej výkonnosti | 9.36% | 29.76% | 8.29% | 6.15% | 4.63% |
Long | Short | Net | |
---|---|---|---|
Stock | 98.38% | 98.38% | |
Bond | |||
Other | 0.58% | 0.58% | |
Cash | 1.94% | 0.90% | 1.04% |
Aktíva | 12,513 mil. |
Počet akcíí | 88 |
Počet dlhopisov | 1 |
Priebež. popl. | 1.81 |
z toho Mng. popl. | 1.50 |
Výk. prémia | |
Trans. popl. | 0.04 |
Dividenda | |
Dividendový výnos | |
Rozhodný dátum | |
Frekvencia výplaty |
Giant | 3.69% |
Large | 23.23% |
Medium | 15.87% |
Small | 20.53% |
Micro | 27.99% |
P/E | 17.01% |
P/BV | 3.72% |
Basic Materials | 1.06% |
Healthcare | 94.96% |
Corporate | 0.58 |
Derivatives | 1.04 |
Výnos do splatnosti p.a. | |
Modifikovaná durácia |
AAA | 0.00 |
AA | 76.61 |
A | 0.00 |
BBB | 0.00 |
BB | 0.00 |
B | 0.00 |
Below B | 0.00 |
Not Rated | 23.39 |
United States | 83.38% |
Canada | 1.02% |
Latin America | |
United Kingdom | 4.57% |
Eurozone | 4.03% |
Europe - ex Euro | 4.07% |
Europe - Emerging | |
Africa | |
Middle East | |
Japan | |
Australasia | |
Asia - Developed | |
Asia - Emerging | |
Emerging Market | |
Developed Country | 97.07% |
Not Classified |
Spoločnosť | Subsektor | Váha | Spoločnosť | Subsektor | Váha |
---|---|---|---|---|---|
Amgen Inc | Healthcare | 7.08% | Regeneron Pharmaceuticals Inc | Healthcare | 6.34% |
Vertex Pharmaceuticals Inc | Healthcare | 5.39% | Ascendis Pharma A/S ADR | Healthcare | 4.07% |
AstraZeneca PLC ADR | Healthcare | 3.69% | Biogen Inc | Healthcare | 3.15% |
Gilead Sciences Inc | Healthcare | 2.99% | Intra-Cellular Therapies Inc | Healthcare | 2.91% |
Jazz Pharmaceuticals PLC | Healthcare | 2.69% | Neurocrine Biosciences Inc | Healthcare | 2.64% |